2023 IPO
Allurion Technologies Stock
Medical devices for weight loss
Sign up today and learn more about Allurion Technologies Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Allurion Technologies Stock
Allurion Technologies is developing a medical device for weight loss that can be delivered and removed without surgery or endoscopy.
Investors
IDO Investments
The Family
Romulus Capital
Cogito, Allurion Technologies, Ceres Imaging, ZeroCater, Romulus Capital
Funding History
July 2012 | $1.7M |
---|---|
April 2013 | $2.9M |
July 2014 | $5.5M |
July 2017 | $27.3M |
Management
Chief Executive Office
Jonathan Wecker
Co-Founder
Samuel Levy
Co-Founder
Shantanu Gaur
Press
mpo-mag - Oct, 4 2023
Allurion Welcomes Two New Top Executivesbusinesswire - Jul, 24 2023
Allurion Technologies, Inc. and Compute Health Acquisition Corp. Remind Stockholders to Vote in Favor of Proposed Business Combinationeconomictimes - Sep, 8 2022
US-based Allurion Technologies launches its weight loss gastric balloon in India